| 1 |
Kerkar N, Lakhole A. Pediatric liver transplantation: a North American perspective[J]. Expert Rev Gastroenterol Hepatol, 2016, 10(8)：949-959.
|
| 2 |
Ferrarese A, Cattelan A, Cillo U, et al. Invasive fungal infection before and after liver transplantation[J]. World J Gastroenterol, 2020, 26(47)：7485-7496.
|
| 3 |
Ghembaza A, Vautier M, Cacoub P, et al. Risk factors and prevention of pneumocystis jirovecii pneumonia in patients with autoimmune and inflammatory diseases[J]. Chest, 2020, 158(6)：2323-2332.
|
| 4 |
Pereira-Díaz E, Moreno-Verdejo F, de la Horra C, et al. Changing trends in the epidemiology and risk factors of pneumocystis pneumonia in Spain[J]. Front Public Health, 2019, 7：275.
|
| 5 |
Weyant RB, Kabbani D, Doucette K, et al. Pneumocystis jirovecii: a review with a focus on prevention and treatment[J]. Expert Opin Pharmacother, 2021，22(12)：1579-1592.
|
| 6 |
Baldwin WR, Valujskikh A, Fairchild RL. Mechanisms of antibody-mediated acute and chronic rejection of kidney allografts[J]. Curr Opin Organ Transplant, 2016，21(1)：7-14.
|
| 7 |
Musat AI, Pigott CM, Ellis TM, et al. Pretransplant donor-specific anti-HLA antibodies as predictors of early allograft rejection in ABO-compatible liver transplantation[J]. Liver Transpl, 2013, 19(10)：1132-1141.
|
| 8 |
Demetris AJ, Bellamy C, Hubscher SG, et al. 2016 comprehensive update of the Banff Working Group on Liver Allograft Pathology: introduction of antibody-mediated rejection[J]. Am J Transplant, 2016, 16(10)：2816-2835.
|
| 9 |
Del BA, Congy-Jolivet N, Danjoux M, et al. De novo donor-specific anti-HLA antibodies mediated rejection in liver-transplant patients[J]. Transpl Int, 2015, 28(12)：1371-1382.
|
| 10 |
Lee BT, Fiel MI, Schiano TD. Antibody-mediated rejection of the liver allograft: an update and a clinico-pathological perspective[J]. J Hepatol, 2021, 75(5)：1203-1216.
|
| 11 |
Egawa H, Ohdan H, Saito K. Current status of ABO-incompatible liver transplantation[J]. Transplantation, 2023, 107(2)：313-325.
|
| 12 |
Sethi S, Jordan SC. Novel therapies for treatment of antibody-mediated rejection of the kidney[J]. Curr Opin Organ Transplant, 2023, 28(1)：29-35.
|
| 13 |
Abramyan S, Hanlon M. Kidney transplantation[M]. Treasure lsland (FL): StatPearls Publishing, 2025.
|
| 14 |
Tasaka S． Recent advances in the diagnosis and management of pneumocystis pneumonia[J]. Tuberc Respir Dis (Seoul), 2020, 83(2)：132-140.
|
| 15 |
Kostakis ID, Sotiropoulos GC, Kouraklis G. Pneumocystis jirovecii pneumonia in liver transplant recipients: a systematic review[J]. Transplant Proc, 2014, 46(9)：3206-3208.
|
| 16 |
Fishman JA, Gans H. Pneumocystis jirovecii in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice[J]. Clin Transplant, 2019, 33(9)：e13587.
|
| 17 |
Zhou S, Aitken SL. Prophylaxis against pneumocystis jirovecii pneumonia in adults[J]. JAMA, 2023, 330(2)：182-183.
|
| 18 |
Brakemeier S, Pfau A, Zukunft B, et al. Prophylaxis and treatment of pneumocystis jirovecii pneumonia after solid organ transplantation[J]. Pharmacol Res, 2018, 134：61-67.
|
| 19 |
Trubin PA, Azar MM. Current concepts in the diagnosis and management of pneumocystis pneumonia in solid organ transplantation[J]. Infect Dis Clin North Am, 2023, 37(3)：617-640.
|
| 20 |
Jin F, Liu XH, Chen WC, et al. High initial (1, 3) beta-d-glucan concentration may be a predictor of satisfactory response of caspofungin combined with TMP/SMZ for HIV-negative patients with moderate to severe pneumocystis jirovecii pneumonia[J]. Int J Infect Dis, 2019, 88：141-148.
|
| 21 |
Utili R, Durante-Mangoni E, Basilico C, et al. Efficacy of caspofungin addition to trimethoprim-sulfamethoxazole treatment for severe pneumocystis pneumonia in solid organ transplant recipients[J]. Transplantation, 2007, 84(6)：685-688.
|
| 22 |
Zhang G, Chen M, Zhang S, et al. Efficacy of caspofungin combined with trimethoprim/sulfamethoxazole as first-line therapy to treat non-HIV patients with severe pneumocystis pneumonia[J]. Exp Ther Med, 2018, 15(2)：1594-1601.
|
| 23 |
Shimizu Y, Sunaga N, Dobashi K, et al. Serum markers in interstitial pneumonia with and without pneumocystis jirovecii colonization: a prospective study[J]. BMC Infect Dis, 2009, 9：47.
|